Read Occupational Therapist Samar Muslemani’s Early Career Blog

Read the latest early career blog post, from NMD4C member Samar Muslemani, OT, M.Sc.

Full blog available here!


Excerpt:

“Occupational therapy is where science, creativity, and compassion collide”

This is a quote from Jessica Kensky, a survivor of the 2013 Boston Marathon bombing and keynote speaker at the 2016 American Occupational Therapy Association welcome ceremony. To me, this quote represents exactly what I love about my profession. Pursuing a PhD allows me to develop these three elements even further.


Samar Muslemani holds a Master’s Degree in Occupational Therapy and has been practicing in Saguenay, Québec since 2018. She is a doctoral student with the University of Sherbrooke. She aims to better understand the functional impacts of cognitive impairments in people living with myotonic dystrophy type 1. She completed a research Master’s Degree in Health Sciences in August 2021. Her project aimed to document independence and social participation of adults living with childhood phenotype of DM1. She received a bursary of the Fonds de recherche du Québec – Santé (FRQS), and has assessed patients both in Canada and France as part of her research project. Native from Saguenay-Lac-Saint-Jean region, she is interested in offering more support to patients and families with neuromuscular diseases (NMD) in her native region and internationally. Both in her research and clinical practice, she has worked with various NMDs, such as recessive spastic ataxia of Charlevoix-Saguenay, oculopharyngeal muscular dystrophy and Charcot-Marie-Tooth diseases. She is the first author of a practical guideline to support occupational therapists in addressing sexuality with their NMD patients. 

Within the NMD4C, Samar supports the Knowledge Translation team through developing knowledge and skills, defining barriers, and reducing the knowledge-to-action gap by developing various tools including clinical practice guidelines in the NMD field. 

Samar Muslemani EC Blog

Read next...

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

RQAS logo

Quebec Network RĂ©seau QuĂ©bĂ©coise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C

2024 year in review

NMD4C 2024 Year in Review

This year in review outlines a collection of achievements from the network over the past year.

2025 NM fellowship funding recipients

NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!

Meet the Basic Science Trainee Committee

NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers

The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.